Debiopharm International SA: VIVOSENSE ANNOUNCES CLOSING OF

Proceeds to accelerate the collection and use of wearable sensor data in clinical trials along with the development of novel digital biomarkers Funding round co-led by the Perceptive Xontogeny

Related Keywords

Tanja Dowe , Lance Myers , Rachel Ford Hutman , Patrick Morrow , Kostenloser Wertpapierhandel , Dudley Tabakin , Chris Garabedian , Patrick Hankey , Head Of Communications , Twitter , Prnewswire Vivosense Inc , Fund Contact , Vivosense Inc , Fund Is Perceptive Advisor , Business Development , Debiopharm Innovation Fund , Perceptive Xontogeny Venture , Switzerland Based Debiopharm Innovation , Debiopharm Innovation , Perceptive Advisor , Ford Hutman , Ford Hutman Media , Investor Relations , Perceptive Advisors , Debiopharm , Nternational , Vivosense , Nnounces , Closing , Series , Financing ,